Open AccessPathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification
Author(s) -
I. Echavarria,
S. Lopez-Tarruella,
A. Picornell,
J.A. García-Saenz,
Y. Jerez,
K. Hoadley,
H.L. Gomez,
F. Moreno,
M.D. Monte-Millan,
I. Marquez-Rodas,
E. Alvarez,
R. Ramos-Medina,
J. Gayarre,
T. Massarrah,
I. Ocaña,
M. Cebollero,
H. Fuentes,
A. Barnadas,
A.I. Ballesteros,
U. Bohn,
C.M. Perou,
M. Martin
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/s9m1-7t60
Subject(s) - docetaxel , carboplatin , triple negative breast cancer , medicine , triple negative , oncology , pathological , breast cancer , cohort , complete response , chemotherapy , cancer , cisplatin